AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Clin Nutr 90: 225-233, 2009. First published May 27, 2009; doi:10.3945/ajcn.2009.27709
American Journal of Clinical Nutrition, doi:10.3945/ajcn.2009.27709
Vol. 90, No. 1, 225-233, July 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/1/225    most recent
ajcn.2009.27709v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by McDermid, J. M
Right arrow Articles by Prentice, A. M
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDermid, J. M
Right arrow Articles by Prentice, A. M
Agricola
Right arrow Articles by McDermid, J. M
Right arrow Articles by Prentice, A. M
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction1,2,3

Joann M McDermid, Maarten F Schim van der Loeff, Assan Jaye, Branwen J Hennig, Chris Bates, Jim Todd, Giorgio Sirugo, Adrian V Hill, Hilton C Whittle and Andrew M Prentice

1 From the Division of Nutritional Sciences, Cornell University, Ithaca, NY (JMM); the Medical Research Council International Nutrition Group, Nutrition and Public Health Intervention Research Unit, Department of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom (JMM, BJH, and AMP); Medical Research Council Laboratories, Fajara, The Gambia (MFSvdL, AJ, GS, and HCW); the Tropical Epidemiology Group, Infectious Disease Epidemiology Unit, Department of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom (JT); Ospedale San Pietro FBF, Rome, Italy (GS); the Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom (BJH and AVH); and the Micronutrient Status Research Section, Medical Research Council Human Nutrition Research, Cambridge, United Kingdom (CB).

2 Supported by the Bristol Myers Squibb Mead Johnson Unrestricted Grant Programme, the Canadian Institutes for Health Research, Canadian Women’s Club Centennial Scholarship Fund, the Gordon Smith Travel Scholarship, the Medical Research Council (United Kingdom), and the Overseas Research Student Awards Scheme and the Wellcome Trust.

3 Address reprint requests and correspondence to JM McDermid, Division of Nutritional Sciences, Cornell University, 310 Savage Hall, Ithaca, NY 14853. E-mail: jmm585{at}cornell.edu.

Background: Iron-related genes and iron status may independently contribute to variable HIV outcomes. The nature of the biologically plausible gene-nutrient interaction remains unknown.

Objectives: The objectives were to investigate whether iron-related genotypes and clinically abnormal iron status independently predict mortality in HIV and whether a gene-nutrient interaction exists.

Design: Baseline plasma, DNA, and clinical data were obtained from 1362 HIV-seropositive Gambian adults followed for 11.5 y to ascertain all-cause mortality. Iron status was estimated on the basis of plasma iron, soluble transferrin receptor (sTfR), ferritin, transferrin, transferrin index, and log(sTfR/ferritin). One haptoglobin (HP) and 5 SLC11A1 (NRAMP1) polymorphisms were genotyped.

Results: SLC11A1-SLC3 and CAAA polymorphisms were the best independent genetic predictors of mortality [adjusted mortality rate ratio (95% CI)]: SLC3:G/C = 0.59 (95% CI: 0.45, 0.85), CAAA:del/ins = 1.51 (95% CI: 1.10, 2.07). In an adjusted model that included all polymorphisms, SLC1:199/199, SLC1:other/other, SLC6a:A/A, and CAAA:del/ins were associated with significantly greater mortality, whereas Hp 2–1 and SLC3:G/C were protective. In unadjusted analyses, all biomarker concentrations were significantly associated with mortality. In an extension of previous findings, both low and elevated iron states were associated with mortality, but the nature of the risk was variable, with linear, inversely linear, and U-shaped associations depending on the biomarker. Mortality was significantly lower in HIV-2 than in HIV-1 infection in the presence of abnormal (low or elevated) iron status. A gene-iron interaction was detected (likelihood-ratio test P = 0.018); however, subject numbers restricted category-specific interpretation.

Conclusions: Iron-related genes, iron status, and their interaction predict mortality in HIV. These findings illustrate the complexity and uncertainty surrounding best practice for managing abnormal iron status and anemia during HIV infection and in regions with a high risk of infection.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society for Nutrition